Oxnard Man Sentenced To Five Years In Prison For Brokering Sale Of Fentanyl Pills
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Oxnard Man Sentenced To Five Years In Prison For Brokering Sale Of Fentanyl Pills

Oxnard Man Sentenced To Five Years In Prison For Brokering Sale Of Fentanyl Pills

September 22, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Akilah Johnson
Phone Number: (415) 436-7994

SAN FRANCISCO - King Edward Harris II was sentenced today to five years in prison for distributing fentanyl pills, announced United States Attorney Brian J. Stretch and Drug Enforcement (DEA) Special Agent in Charge John J. Martin.

Harris, 35, of Oxnard, pleaded guilty on April 7, 2017, to six counts of distributing and possessing with intent to distribute fentanyl.  According to the plea agreement, Harris admitted that, over the course of six transactions, he brokered the sale of over 2,300 counterfeit oxycodone pills created by a supplier operating a pill press in San Francisco.  Although the pills were marked as genuine oxycodone pills, they were instead laced with fentanyl.  Harris admitted that, in total, the pills contained over 160 grams of fentanyl. 

On November 29, 2016, federal grand jury returned a superseding indictment charging Harris with conspiracy to distribute fentanyl, as well as six counts of distribution and possession with intent to distribute fentanyl, in violation of 21 U.S.C. § 841(a)(1). 

Fentanyl is a dangerous and highly potent opiate about 100 times more powerful than morphine.  Just two milligrams of fentanyl can constitute a lethal dose.  Fentanyl is particularly dangerous when it is used to create counterfeit pills.  Illegal pill press operations will sometimes use fentanyl, which is cheaper than other opiates, to create fake pills that are stamped to look like genuine oxycodone pills.  Because fentanyl is such a powerful opiate, a small difference in the amount of fentanyl in a homemade pill can make a huge difference in its potency.  Counterfeit pills containing fentanyl have already been linked to numerous unintentional overdoses by users who believed they were ingesting a much less powerful opiate.

“Counterfeit pills made with fentanyl represent a fearsome public safety threat to our communities and intensify the opioid crisis,” said U.S. Attorney Stretch.  “The distribution of fentanyl must be stopped and our office will continue to fight against its devastating effects on the men, women and children in northern California.” 

The sentence was handed down by the Honorable Susan Illston, U.S. District Judge, following Harris’s guilty plea.  Judge Illston also sentenced the defendant to a five-year period of supervised release.  The defendant was remanded into federal custody and will begin serving the sentence immediately.

Assistant U.S. Attorney Rita Lin is prosecuting the case with the assistance of Amanda Martinez, Rawaty Yim, Theresa Benitez, and Wincy Wong.  The prosecution is the result of an investigation by the DEA, United States Postal Inspector, Immigration and Customs Enforcement’s Homeland Security Investigations, and the Internal Revenue Service.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Bob P. Beris, Special Agent in Charge - San Francisco
@DEASanFrancisco
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster